News

On July 8, 2017 the federal court overseeing the first class action lawsuit filed against Wells Fargo related to unauthorized accounts granted preliminary approval to a $142 million settlement designed to compensate Wells Fargo customers nationwide.

Michael Woerner and a team of attorneys, are investigating cases involving patients who took Invokana, Invokamet, or Invokamet XR and suffered an amputation as a result.

The cases seek to make the care and treatment for Type 1 and Type 2 Diabetes Patients more affordable and increase pricing transparency in the pharmaceutical industry.

Details have come to light about a conspiracy among manufacturers of automobile door locking mechanisms that has had the effect of raising the price of that vital component and hence of any car that includes one of those latches.

Keller Rohrback is investigating the increased risk of leg and foot amputations when taking the SGLT2 inhibitors: Invokana, Invokamet, Invokamet XR for the treatment of type 2 diabetes.

The Joint Panel on Multidistrict Litigation consolidated all of the EcoDiesel cases in courts across the country before Judge Edward M. Chen of the Northern District of California.

Keller Rohrback L.L.P. is investigating recent reports that Wells Fargo has been improperly charging customers fees to extend their promised interest rate when their mortgage paperwork was delayed.

Keller Rohrback continues to work on behalf of owners of EcoDiesel Ram 1500 and Jeep Grand Cherokee vehicles

Bosch, while not admitting liability, has agreed to pay owners of the affected vehicles $327.5 million dollars.